Asthma: recent developments in treatment.
D000208:Acute Disease; D000628:Aminophylline / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D001250:Asthma, Exercise-Induced / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000627:therapeutic use; D019819:Budesonide; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004205:Cromolyn Sodium / Q000627:therapeutic use; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D011282:Pregnenediones / Q000627:therapeutic use; D012293:Rifampin / Q000009:adverse effects; D013806:Theophylline / Q000506:poisoning
D001993:Bronchodilator Agents; D002121:Calcium Channel Blockers; D010276:Parasympatholytics; D011282:Pregnenediones; D000628:Aminophylline; D019819:Budesonide; D013806:Theophylline; D004205:Cromolyn Sodium; D001241:Aspirin; D012293:Rifampin